HKD 1.77
(-1.12%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 812.91 Million CNY | 370.56% |
2022 | 349.17 Million CNY | -174.09% |
2021 | 388.69 Million CNY | -76.27% |
2020 | 1.63 Billion CNY | 26.25% |
2019 | 1.29 Billion CNY | 260.93% |
2018 | 359.41 Million CNY | -36.46% |
2017 | 565.64 Million CNY | -38.06% |
2016 | 913.26 Million CNY | 640.14% |
2015 | -169.07 Million CNY | -14.46% |
2014 | -147.71 Million CNY | -166.95% |
2013 | 220.64 Million CNY | -69.55% |
2012 | 739.94 Million CNY | 23.25% |
2011 | 588.4 Million CNY | 43.49% |
2010 | 409.78 Million CNY | -1.63% |
2009 | 416.57 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 735.86 Million CNY | 0.0% |
2023 Q2 | -395.29 Million CNY | 0.0% |
2023 FY | - CNY | 370.56% |
2023 Q4 | 901.49 Million CNY | 0.0% |
2022 Q4 | -373.92 Million CNY | 0.0% |
2022 FY | - CNY | -174.09% |
2022 Q2 | 88.92 Million CNY | 0.0% |
2021 FY | - CNY | -76.27% |
2021 Q4 | -144.09 Million CNY | 0.0% |
2021 Q2 | 532.78 Million CNY | 0.0% |
2020 Q2 | 628.27 Million CNY | 0.0% |
2020 Q4 | 1 Billion CNY | 0.0% |
2020 FY | - CNY | 26.25% |
2019 Q4 | 960.39 Million CNY | 0.0% |
2019 Q2 | 336.82 Million CNY | 0.0% |
2019 FY | - CNY | 260.93% |
2018 FY | - CNY | -36.46% |
2018 Q2 | 142.56 Million CNY | 0.0% |
2018 Q4 | 216.85 Million CNY | 0.0% |
2017 FY | - CNY | -38.06% |
2017 Q2 | 194.83 Million CNY | 0.0% |
2017 Q4 | 370.81 Million CNY | 0.0% |
2016 Q2 | 222.52 Million CNY | 0.0% |
2016 FY | - CNY | 640.14% |
2016 Q4 | 690.74 Million CNY | 0.0% |
2015 Q4 | -8.03 Million CNY | 0.0% |
2015 FY | - CNY | -14.46% |
2015 Q2 | -161.04 Million CNY | 0.0% |
2014 FY | - CNY | -166.95% |
2014 Q4 | -129.36 Million CNY | 0.0% |
2014 Q2 | -18.35 Million CNY | 0.0% |
2013 Q4 | 97.51 Million CNY | 0.0% |
2013 Q2 | 123.13 Million CNY | 0.0% |
2013 FY | - CNY | -69.55% |
2012 Q1 | 181.48 Million CNY | 0.0% |
2012 Q3 | 181.48 Million CNY | 0.0% |
2012 Q2 | 181.48 Million CNY | 0.0% |
2012 Q4 | 232.52 Million CNY | 28.12% |
2012 FY | - CNY | 23.25% |
2011 Q4 | 181.48 Million CNY | 23.55% |
2011 Q2 | 146.89 Million CNY | 0.0% |
2011 FY | - CNY | 43.49% |
2011 Q3 | 146.89 Million CNY | 0.0% |
2011 Q1 | 146.89 Million CNY | 0.0% |
2010 FY | - CNY | -1.63% |
2010 Q3 | 102.39 Million CNY | 0.0% |
2010 Q4 | 146.89 Million CNY | 43.45% |
2010 Q1 | 102.39 Million CNY | 0.0% |
2010 Q2 | 102.39 Million CNY | 0.0% |
2009 Q2 | 99.62 Million CNY | 0.0% |
2009 FY | - CNY | 0.0% |
2009 Q3 | 99.62 Million CNY | 0.0% |
2009 Q4 | 102.39 Million CNY | 2.79% |
2009 Q1 | 99.62 Million CNY | 0.0% |
2008 Q4 | 99.62 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | -5358.363% |
Lee & Man Chemical Company Limited | 597.01 Million HKD | -36.163% |